Top Markets
#1 Status Status +12.47%
#2 TENDIES TENDIES +7.93%
#3 Ontology Gas Ontology Gas +7.80%
#4 StonkBroker StonkBroker +7.11%
#5 Wrapped Flare Wrapped Flare +4.36%
#6 Tutorial Tutorial +3.31%
#7 Nano Nano +3.23%
#8 Atoshi Atoshi +2.82%
#9 SPX6900 SPX6900 +2.71%
#10 Gas Gas +2.33%
Coin of the day
Status Status
설정
언어
한국어
통화
USD
테마
Jiangxi Fushine Pharmaceutical Co., Ltd. Jiangxi Fushine Pharmaceutical Co., Ltd.

Jiangxi Fushine Pharmaceutical Co., Ltd.

300497
주식 순위 #8174
Jiangxi Fushine Pharmaceutical Co., Ltd. is engaged in the global research,... Jiangxi Fushine Pharmaceutical Co., Ltd. is engaged in the global research, development, production, and marketing of active pharmaceutical ingredients (APIs) and key chemical compounds for drug synthesis. Its product portfolio includes important antibiotics like penicillin and carbapenem, alongside a variety of other pharmaceutical offerings. The company also extends its expertise by providing contract research, development, and manufacturing services. Founded in 2002 and headquartered in Jingdezhen, China, the firm was initially named Jingdezhen Fuxiang Pharmaceutical Co., Ltd. before adopting its current designation in August 2012.
주가
$2.49
마지막 동기화: 2026-08-28
시가총액
$1.34B
변동 (1일)
0.41%
변동 (1년)
78.39%
국가
CN
거래 Jiangxi Fushine Pharmaceutical Co., Ltd. (300497)

카테고리

Healthcare
Jiangxi Fushine Pharmaceutical Co., Ltd. (300497)의 P/S 비율
2026 기준 P/S 비율 TTM: 0
Jiangxi Fushine Pharmaceutical Co., Ltd.의 최신 재무 보고서와 주가에 따르면 현재 P/S 비율(TTM)은 0입니다. 2026년 말 기준 P/S 비율은 0였습니다.
Jiangxi Fushine Pharmaceutical Co., Ltd.의 P/S 비율 기록 (2026 ~ 2026)
매년 말 P/S 비율
연도 P/S 비율 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 P/S 비율
회사 P/S 비율 P/S 비율 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH